
11 - 50 employees
Founded 2021
🧬 Biotechnology
🔬 Science
🤝 B2B
💰 $45M Series A - Spear Bio on 2024-07
Biotechnology • Science • B2B
Spear Bio is a biotechnology company that develops and sells ultra-sensitive protein biomarker detection assays and related reagents and services. Their proprietary SPEAR UltraDetect technology uses a two-factor authenticated, homogeneous (wash-free) format to detect trace protein biomarkers in single-molecule ranges from ultra-small sample volumes, and they offer assay kits (e. g. , pTau217, pTau231, GFAP, NF-L), reaction kits, automation accessories, data analysis, and evaluation/research accelerator services for applications in neurology, immunology, and infectious disease research.
🕒 Yesterday
Part-time Laboratory Director overseeing operations of CLIA-certified clinical laboratory for Spear Bio. Focused on clinical, scientific, and regulatory oversight to ensure accurate testing services.
🍂 Massachusetts – Remote
💵 $0 - $1 / hour
💰 $45M Series A - Spear Bio on 2024-07
⏱ Part Time
🔴 Lead
👨⚕️ Medical Director
🦅 H1B Visa Sponsor
🕒 February 27
Business Development Manager at Spear Bio introducing ultra-sensitive Immunoassays to the Life Sciences and CRO markets. Seeking candidates with strong neuroscience network on the East or West Coast.
🍂 Massachusetts – Remote
💵 $150k - $160k / year
💰 $45M Series A - Spear Bio on 2024-07
⏰ Full Time
🟡 Mid-level
🟠 Senior
💰 Business Development (BDR)
🦅 H1B Visa Sponsor